M Pirro1, C Leli, G Fabbriciani, M R Manfredelli, L Callarelli, F Bagaglia, A M Scarponi, E Mannarino. 1. Unit of Internal Medicine, Angiology and Arteriosclerosis Diseases, Department of Clinical and Experimental Medicine, University of Perugia, Hospital "Santa Maria della Misericordia", Piazzale Menghini, 1-06129 Perugia, Italy. mpirro@unipg.it
Abstract
UNLABELLED: The role of circulating osteoprogenitor cells in postmenopausal osteoporosis is unknown. We found that alkaline-phosphatase-positive (AP+) cells are the lacking cells in osteoporosis, whose reduction is related to bone loss. Conversely, the increased number of alkaline phosphatase/CD34-positive cells may reflect the reactive bone marrow contribution to bone formation. INTRODUCTION: Circulating osteoprogenitor cells mineralize in vitro and in vivo. Loss of osteogenic cells may account for bone loss in osteoporosis. We studied whether there is an association between the number of circulating osteoprogenitor cells and bone mineral density (BMD) in postmenopausal women with and without osteoporosis. METHODS: The number of circulating AP+, osteocalcin-positive (OCN+), AP+/CD34+, and OCN+/CD34+ cells was quantified in 54 postmenopausal osteoporotic women and 36 age-matched nonosteoporotic controls. RESULTS: The number of AP+ cells was lower in osteoporotic women than in controls (127 +/- 16 vs 234 +/- 23 per microliter; p < 0.001); higher levels of AP+/CD34+, OCN+, and OCN+/CD34+ cells were found in osteoporotic than controls (p < 0.01 for all). The number of AP+ cells was correlated with lumbar BMD (rho = 0.29; p = 0.008) and proximal femur BMD (rho = 0.31; p = 0.005) whereas inverse correlations were found between AP+/CD34+ cells, OCN+, OCN+/CD34+, and BMD. Reduced AP+ cells and increased AP+/CD34 +, OCN+, and OCN+/CD34+ cells were predictors of low BMD, independent of traditional risk factors for osteoporosis. CONCLUSION: In postmenopausal osteoporotic women, a reduced number of circulating AP+ cells and increased levels of AP+/CD34+, OCN+, and OCN+/CD34+ cells are associated with reduced bone mineral density, the interpretation of such a cellular imbalance needing exploration.
UNLABELLED: The role of circulating osteoprogenitor cells in postmenopausal osteoporosis is unknown. We found that alkaline-phosphatase-positive (AP+) cells are the lacking cells in osteoporosis, whose reduction is related to bone loss. Conversely, the increased number of alkaline phosphatase/CD34-positive cells may reflect the reactive bone marrow contribution to bone formation. INTRODUCTION: Circulating osteoprogenitor cells mineralize in vitro and in vivo. Loss of osteogenic cells may account for bone loss in osteoporosis. We studied whether there is an association between the number of circulating osteoprogenitor cells and bone mineral density (BMD) in postmenopausal women with and without osteoporosis. METHODS: The number of circulating AP+, osteocalcin-positive (OCN+), AP+/CD34+, and OCN+/CD34+ cells was quantified in 54 postmenopausal osteoporoticwomen and 36 age-matched nonosteoporotic controls. RESULTS: The number of AP+ cells was lower in osteoporoticwomen than in controls (127 +/- 16 vs 234 +/- 23 per microliter; p < 0.001); higher levels of AP+/CD34+, OCN+, and OCN+/CD34+ cells were found in osteoporotic than controls (p < 0.01 for all). The number of AP+ cells was correlated with lumbar BMD (rho = 0.29; p = 0.008) and proximal femur BMD (rho = 0.31; p = 0.005) whereas inverse correlations were found between AP+/CD34+ cells, OCN+, OCN+/CD34+, and BMD. Reduced AP+ cells and increased AP+/CD34 +, OCN+, and OCN+/CD34+ cells were predictors of low BMD, independent of traditional risk factors for osteoporosis. CONCLUSION: In postmenopausal osteoporoticwomen, a reduced number of circulating AP+ cells and increased levels of AP+/CD34+, OCN+, and OCN+/CD34+ cells are associated with reduced bone mineral density, the interpretation of such a cellular imbalance needing exploration.
Authors: Guiti Z Eghbali-Fatourechi; Jesse Lamsam; Daniel Fraser; David Nagel; B Lawrence Riggs; Sundeep Khosla Journal: N Engl J Med Date: 2005-05-12 Impact factor: 91.245
Authors: Guiti Z Eghbali-Fatourechi; Ulrike I L Mödder; Natthinee Charatcharoenwitthaya; Arunik Sanyal; Anita H Undale; Jackie A Clowes; James E Tarara; Sundeep Khosla Journal: Bone Date: 2007-01-04 Impact factor: 4.398
Authors: Elizabeth A Olmsted-Davis; Zbigniew Gugala; Fernando Camargo; Francis H Gannon; KathyJo Jackson; Kirsten Anderson Kienstra; H David Shine; Ronald W Lindsey; Karen K Hirschi; Margaret A Goodell; Malcolm K Brenner; Alan R Davis Journal: Proc Natl Acad Sci U S A Date: 2003-12-12 Impact factor: 11.205
Authors: Mario Gössl; Ulrike I Mödder; Elizabeth J Atkinson; Amir Lerman; Sundeep Khosla Journal: J Am Coll Cardiol Date: 2008-10-14 Impact factor: 24.094
Authors: P D'Amelio; C Tamone; F Sassi; L D'Amico; I Roato; S Patanè; M Ravazzoli; L Veneziano; R Ferracini; G P Pescarmona; G C Isaia Journal: Osteoporos Int Date: 2011-05-27 Impact factor: 4.507
Authors: Anita Undale; Bhuma Srinivasan; Matthew Drake; Louise McCready; Elizabeth Atkinson; James Peterson; B Lawrence Riggs; Shreyasee Amin; U I Modder; U I Moedder; Sundeep Khosla Journal: Bone Date: 2010-03-31 Impact factor: 4.398
Authors: Pilar Peris; Elizabeth J Atkinson; Mario Gössl; Trevor L Kane; Louise K McCready; Amir Lerman; Sundeep Khosla; Ulrike I McGregor Journal: Mayo Clin Proc Date: 2012-12-08 Impact factor: 7.616
Authors: John S Manavalan; Stephen Arpadi; Shenthuraan Tharmarajah; Jayesh Shah; Chiyuan A Zhang; Marc Foca; Natalie Neu; David L Bell; Kyle K Nishiyama; Stavroula Kousteni; Michael T Yin Journal: J Bone Miner Res Date: 2016-07-06 Impact factor: 6.741